The global IVF market was valued at USD 3.73 billion in 2024 and is projected to reach USD 14.63 billion by 2033, growing at a CAGR of 16.4% from 2025 to 2033. Behind every cycle counted in that market figure is an IVF laboratory – a controlled clinical environment in which embryologists manage the most technically demanding stages of assisted reproduction, and in which the quality of equipment, consumables, protocols, and infrastructure directly determines clinical outcomes for patients.

This guide covers IVF laboratory equipment, cryo IVF, embryo cryopreservation, cryopreservation equipment selection, and LN2 supply infrastructure as they apply to fertility clinics and IVF laboratories seeking to build or improve their cryogenic programme.

What IVF laboratory equipment does a complete cryopreservation programme require?

The IVF laboratory equipment required for a complete cryopreservation programme covers several distinct categories, each with a specific function in the workflow from oocyte retrieval through to long-term storage and frozen embryo transfer.

The liquid nitrogen storage vessel is the foundation. A minimum of two dewars provides redundancy if one develops a vacuum fault or requires servicing. Evaporation rate data must be reviewed before purchasing, as this specification determines the daily LN2 consumption, the supply interval, and the safety buffer available if delivery is delayed. The difference between a vessel losing 0.1 litres of LN2 per day and one losing 0.4 litres per day accumulates to 547 litres over five years – a cost gap that frequently exceeds the price premium between vessel tiers.

The vitrification workstation provides the controlled thermal environment for loading embryos and oocytes onto carriers before plunging into liquid nitrogen. Vitrification consumables – carriers, high security straws, cryogenic canes, goblets, canisters, and cryosleeves – are the items that directly contact biological material at every stage of the process. Their quality and consistency directly affect post-thaw viability.

Many IVF laboratories now employ large-capacity LN2 tanks of 160 to 1000 litres equipped with computerised monitoring and temperature sensors, representing a significant evolution from the simple stainless-steel dewars that required manual refilling and provided no automated alert capability.

Safety IVF lab equipment is a regulatory requirement: cryogenic-rated gloves, full face shields, and fixed oxygen depletion monitors in the LN2 storage room.

IVF laboratory equipment standards: what compliance requires

IVF laboratory equipment must meet a combination of regulatory standards and operational performance criteria. In the UK, IVF laboratories operate under HFEA licence and are subject to periodic inspection against the HFEA’s Code of Practice. This requires documented temperature monitoring, vessel inspection logs, LN2 supply contingency plans, and standard operating procedures for all cryogenic activities.

CE marking and UKCA marking apply to medical devices used in IVF laboratories including vitrification carriers and culture consumables. ISO 9001:2015 certification for equipment suppliers provides assurance of quality management system consistency. For all consumables in direct contact with biological material, sterility, biocompatibility, and absence of embryotoxic substances are the critical specifications.

What is cryo IVF and how does it transform fertility treatment?

Cryo IVF refers to the use of cryopreservation as an integral component of IVF treatment, rather than a supplementary option. The shift from fresh embryo transfer as the default approach towards frozen embryo transfer as the primary or preferred route represents one of the most significant clinical evolutions in reproductive medicine.

The global cryopreservation for IVF market was valued at USD 504.58 million in 2025 and is projected to grow at a CAGR of 10.60% during the forecast period of 2025 to 2034, reaching USD 1.24 billion by 2034.

The clinical advantages of cryo IVF include the ability to freeze all embryos in stimulated cycles where OHSS risk is elevated, the opportunity to complete preimplantation genetic testing before transfer, the flexibility to transfer embryos in a subsequent cycle when the uterine environment is optimised, and the ability to store surplus embryos for future family planning without repeat stimulation. For fertility preservation patients, cryo IVF is the entire clinical service. The quality of the cryopreservation process and storage infrastructure determines whether preserved material remains viable when needed, potentially years or decades later.

Embryo cryopreservation: how vitrification works and what determines success

Embryo cryopreservation by vitrification involves exposing the embryo to cryoprotectant agents in a precisely controlled sequence, loading it onto a carrier, and plunging directly into liquid nitrogen at -196°C. Cooling rates of 15,000 to 30,000°C per minute bypass the temperature range at which ice crystal nucleation occurs. The embryo enters a glass-like amorphous state rather than forming damaging ice crystals.

Live birth rates after embryo cryopreservation were reported at 41% per transfer cycle according to a study published by Oxford University Press, with ongoing technological improvements in vitrification techniques continuing to enhance outcomes.

Three factors determine embryo cryopreservation success. Pre-freezing embryo quality is the most significant determinant. The vitrification process itself, including the cryoprotectant protocol, carrier design, and embryologist technical skill, influences cellular damage during cooling. Post-vitrification storage quality determines whether the embryo maintains its preserved state until warming – requiring consistent temperatures below -130°C, adequate LN2 supply, and systematic monitoring.

IVF technology evolution and its implications for cryogenic storage

Time-lapse imaging, artificial intelligence-based embryo selection, and improved cryopreservation techniques are among the technologies boosting IVF success rates, with the IVF segment expected to register the highest CAGR during the forecast period in the assisted reproductive technology market.

AI-based embryo selection systems identify morphokinetic markers associated with implantation potential that are not reliably detectable through conventional assessment. Preimplantation genetic testing requires embryos biopsied at the blastocyst stage to be vitrified while genetic analysis is completed, making cryogenic storage quality critical during the analysis period. IoT-enabled monitoring with remote alarm capability is becoming an expectation in well-run IVF laboratories.

Managing operational risk in the IVF lab cryogenic storage programme

The most consequential operational risks in an IVF lab’s cryogenic programme are LN2 supply failure, dewar vacuum loss, and sample misidentification. LN2 supply failure risk is managed by calculating actual daily consumption across all vessels, establishing a minimum 14-day buffer, setting reorder alerts, and maintaining a secondary emergency supply arrangement. Vacuum failure risk is managed by daily pre-use inspection checking for frost or condensation on the outer shell and abnormal evaporation rate. Sample misidentification is managed by cryogenic-rated labelling on every straw, cane, and canister with a double-check protocol at every handling step.

Between 2025 and 2035, the cryopreservation for IVF market will undergo transformative advancements with the rise of AI-powered cryo-monitoring and automated cryogenic storage tracking, which will optimise frozen embryo selection and reduce cryo-storage risks.

LN2 supply tank management for fertility clinics

An LN2 supply tank is a pressurised vessel – typically 5 to 10 bar operating pressure – used to store bulk liquid nitrogen for dispensing into laboratory storage dewars. In the UK, LN2 supply tanks are subject to the Pressure Systems Safety Regulations 2000, requiring a written scheme of examination, competent person inspection on a defined schedule, and documented maintenance records.

Supply tank sizing must be based on total daily LN2 consumption across all storage vessels, with enough capacity to cover the scheduled delivery interval plus a meaningful safety buffer. Level monitoring with automated low-level alerts and a documented reorder procedure is essential supply infrastructure for any active fertility programme.

What cryo preservation covers: materials, protocols, and applications

Cryo preservation at cryogenic temperatures applies across a broader range of biological materials than IVF alone. Human embryos, oocytes, and sperm are the core clinical applications. Peripheral blood mononuclear cells, stem cells, cord blood, and bone marrow are preserved for transplantation and cell therapy. Ovarian tissue cryopreservation is an emerging technique allowing preservation of thousands of primordial follicles simultaneously. Animal reproductive material supports veterinary medicine and genetic preservation programmes. The common requirement across all applications: maintain temperature below -130°C continuously, with adequate LN2 supply, systematic monitoring, and documented procedures.

How Cryolab supports IVF laboratories and fertility clinics worldwide

Cryolab has supplied cryogenic storage vessels, dry shippers, vitrification consumables, cryogenic canes and cryosleeves, safety equipment, and LN2 supply infrastructure to IVF clinics, fertility units, sperm banks, biobanks, and research institutions for over 40 years. ISO 9001:2015 certified, based in Chichester, Cryolab works directly with embryologists, laboratory managers, and procurement professionals to specify cryogenic solutions suited to the programme, facility, and regulatory requirements of each customer.

Use CryoGPT, Cryolab’s AI assistant for cryogenic and IVF laboratory questions, contact the Cryolab team directly, or browse the full storage vessel range.